Pfizer, Parexel fall on sales reports

Sales slipped to $16.5 billion from $16.6 billion, despite the inclusion of products from recently acquired King Pharmaceuticals. According to a poll by FactSet Research, analysts had been looking for sales of $16.59 billion. Shares of Parexel...